Literature DB >> 10575138

Evidence-based antibiotic therapy of diabetic foot infections.

B A Lipsky1.   

Abstract

In addition to proper cleansing, debridement and local wound care, foot infections in diabetic patients require carefully selected antibiotic therapy. Serious infections necessitate hospitalization for initial parenteral broad-spectrum antibiotic therapy. Appropriately selected patients with mild infections can be treated as outpatients with oral (or even topical) therapy. Initial antibiotic selection is usually empirical, but definitive therapy may be modified based on culture results and the clinical response. Therapy should nearly always be active against staphylococci and streptococci, with broader-spectrum agents indicated if Gram-negative or anaerobic organisms are likely. In infected foot tissues levels of most antibiotics, except fluoroquinolones, are often subtherapeutic. The duration of therapy ranges from a week (for mild soft tissue infections) to over 6 weeks (for osteomyelitis). Recent antibiotic trials have shown that several intravenously or orally administered agents are effective in treating these infections, with no one agent or combination emerging as optimal. Suggested regimens based on the severity of infection are provided.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10575138     DOI: 10.1111/j.1574-695X.1999.tb01398.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  14 in total

Review 1.  Diabetic Foot Infections: an Update in Diagnosis and Management.

Authors:  Pinelopi Grigoropoulou; Ioanna Eleftheriadou; Edward B Jude; Nikolaos Tentolouris
Journal:  Curr Diab Rep       Date:  2017-01       Impact factor: 4.810

2.  Variation in antibiotic treatment for diabetic patients with serious foot infections: a retrospective observational study.

Authors:  Benjamin G Fincke; Donald R Miller; Cindy L Christiansen; Robin S Turpin
Journal:  BMC Health Serv Res       Date:  2010-07-06       Impact factor: 2.655

Review 3.  Optimising antimicrobial therapy in diabetic foot infections.

Authors:  Nalini Rao; Benjamin A Lipsky
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Infections in Diabetic Foot Ulcerations.

Authors:  Warren S. Joseph; James S. Tan
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

5.  Fluoroquinolone therapy for uncomplicated skin and skin structure infections : a retrospective database comparison of treatment duration, failures and charges.

Authors:  Karen N Keating; Howard Friedman; Eleanor M Perfetto
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

6.  Pentoxifylline: a new armamentarium in diabetic foot ulcers.

Authors:  Venkatesh Rewale; Kiran Ravi Prabhakar; Anjali M Chitale
Journal:  J Clin Diagn Res       Date:  2014-01-12

7.  Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.

Authors:  Benjamin A Lipsky; Peter Sheehan; David G Armstrong; Alan D Tice; Adam B Polis; Murray A Abramson
Journal:  Int Wound J       Date:  2007-03       Impact factor: 3.315

8.  Distinguishing colonization from infection with Staphylococcus aureus in diabetic foot ulcers with miniaturized oligonucleotide arrays: a French multicenter study.

Authors:  Albert Sotto; Jean-Louis Richard; Nourredine Messad; Nicolas Molinari; Nathalie Jourdan; Sophie Schuldiner; Ariane Sultan; Christian Carrière; Bertrand Canivet; Luce Landraud; Gérard Lina; Jean-Philippe Lavigne
Journal:  Diabetes Care       Date:  2012-02-01       Impact factor: 19.112

9.  A Novel Chemically Modified Curcumin "Normalizes" Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies.

Authors:  Yazhou Zhang; Steve A McClain; Hsi-Ming Lee; Muna S Elburki; Huiwen Yu; Ying Gu; Yu Zhang; Mark Wolff; Francis Johnson; Lorne M Golub
Journal:  J Diabetes Res       Date:  2016-04-13       Impact factor: 4.011

10.  Development of a Novel Collagen Wound Model To Simulate the Activity and Distribution of Antimicrobials in Soft Tissue during Diabetic Foot Infection.

Authors:  Bianca L Price; Andrew M Lovering; Frank L Bowling; Curtis B Dobson
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.